针对威尔姆斯瘤的WT1-反应性T细胞的细胞毒性:对抗原特异性采用免疫疗法的影响

Seyed Mostafa Monzavi1,2,3, Amir Ali Hamidieh4, Mohammad Vasei5

  • 1Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.

BioImpacts : BI
|September 22, 2023
PubMed
概括

研究人员成功地从威尔姆斯瘤患者中分离了WT1反应性T细胞,证明了它们对威尔姆斯瘤细胞的强大抗瘤活性. 这些T细胞显示出作为WT1表达威尔姆斯瘤的采用性免疫治疗的前景.